TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid them

This publication has 95 references indexed in Scilit:

• TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis
  Journal of Clinical Investigation, 2008
• TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development
  Journal of Clinical Investigation, 2008
• Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
  Nature Medicine, 2007
• Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2
  Molecular and Cellular Biology, 2006
• Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma
  British Journal of Cancer, 2006
• TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma
  Oncogene, 2006
• A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death
  Science, 2004
• Deficient Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor Transport to the Cell Surface in Human Colon Cancer Cells Selected for Resistance to TRAIL-induced Apoptosis
  Journal of Biological Chemistry, 2004
• TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB
  Oncogene, 2003
• Targeting death and decoy receptors of the tumour-necrosis factor superfamily
  Nature Reviews Cancer, 2002